{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/483464556",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/383104340"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#483464556",
  "code": "NE86",
  "source": "http://id.who.int/icd/entity/483464556",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/483464556/postcoordinationScale/associatedWith",
      "axisName": "http://id.who.int/icd/schema/associatedWith",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/460401849",
        "http://id.who.int/icd/release/11/2024-01/mms/1642025150",
        "http://id.who.int/icd/release/11/2024-01/mms/2024436666",
        "http://id.who.int/icd/release/11/2024-01/mms/1162198017",
        "http://id.who.int/icd/release/11/2024-01/mms/431804121"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Malignant hyperthermia due to anaesthesia"
  },
  "definition": {
    "@language": "en",
    "@value": "A condition caused by hypermetabolism in response to certain anaesthetic drugs. This condition is characterised by hyperthermia, tachycardia, tachypnoea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity, and rhabdomyolysis. This condition may be associated with genetic mutation."
  },
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/59436623"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Malignant hyperthermia due to anaesthesia"
      }
    }
  ]
}